Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-21-002365
Filing Date
2021-03-01
Accepted
2021-03-01 07:30:07
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 39585
2 filename2.txt TEXT-EXTRACT 17905
  Complete submission text file 0000000000-21-002365.txt   73160
Mailing Address 1201 N. MARKET STREET SUITE 111 WILMINGTON DE 19801
Business Address 1201 N. MARKET STREET SUITE 111 WILMINGTON DE 19801 484-254-6134
NRX Pharmaceuticals, Inc. (Filed for) CIK: 0001719406 (see all company filings)

EIN.: 822844431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations